Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Geovan Menezes de Sousa

8 papers in the library · 230 citations · publishing 2018-2026

Papers

Brief mindfulness-based training and mindfulness trait attenuate psychological stress in university students: a randomized controlled trial

BMC Psychology February 1, 2021 Geovan Menezes de Sousa, Geissy Lainny de Lima-Araújo, Dráulio Barros de Araújo et al. 90 citations

Higher trait mindfulness is linked to lower anxiety and perceived stress in university students. A brief mindfulness training reduced anxiety state and perceived stress and increased state mindfulness, while both mindfulness and active control groups showed reduced negative affect and cortisol. Changes in state mindfulness mediated increases in positive affect and decreases in perceived stress and cortisol regardless of trait mindfulness, but anxiety reduction occurred only in those with high trait mindfulness. The results suggest that brief mindfulness interventions can help reduce psychological distress in healthy young students.

The impact of a brief mindfulness training on interoception: A randomized controlled trial

PLoS One September 7, 2022 Geissy Lainny de Lima-Araújo, Geovan Menezes de Sousa, Thatiane Aparecida Mendes et al. 64 citations

A brief three-day mindfulness training increased interoceptive sensibility—the self-reported tendency to notice and attend to body signals—in 40 healthy young adults naive to meditation, compared with an active control group. Five of eight subdomains of interoceptive sensibility improved after the training, but interoceptive accuracy (objective performance on a heartbeat-detection task) did not change. The increase in interoceptive sensibility statistically mediated reductions in state anxiety, suggesting a plausible mechanism for the anxiolytic effects of brief mindfulness practices.

Acute effects of ayahuasca in a juvenile non-human primate model of depression

Brazilian Journal of Psychiatry November 21, 2018 Flávia S. Da Silva, Erick Allan Dos Santos Silva, Geovan Menezes de Sousa et al. 46 citations

In a juvenile marmoset model of depression, a single dose of ayahuasca reversed stress-induced hypocortisolemia within 24 hours, reduced stereotypic scratching in males, increased feeding in males, and restored body weight in both sexes, with behavioral effects lasting up to 14 days. Saline vehicle did not produce these effects. The findings suggest ayahuasca may have rapid and sustained antidepressant properties, supporting further research into psychedelics for early-onset depression.

Moderators of ayahuasca’s biological antidepressant action

Frontiers in Psychiatry December 5, 2022 Geovan Menezes de Sousa, Vagner Deuel de Oliveira Tavares, Ana Cecília de Menezes Galvão et al. 14 citations

In a double-blind, placebo-controlled trial with 72 participants, ayahuasca's effects on depression-related biomarkers were examined two days after dosing. Larger reductions in depressive symptoms during the session were linked to higher serum cortisol levels in patients with treatment-resistant depression. Smaller changes in salivary cortisol during ayahuasca use were associated with higher brain-derived neurotrophic factor (BDNF) levels in patients who showed greater clinical improvement in depressive symptoms. No moderating effects were found for the cortisol awakening response, interleukin-6, or C-reactive protein in patients, nor for any biomarker in healthy controls or the placebo group. The findings suggest that acute emotional and physiological responses during ayahuasca sessions may influence key biomarkers of depression.

Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior.

Frontiers in Behavioral Neuroscience January 1, 2022 Maria Lara Porpino de Meiroz Grilo, Geovan Menezes de Sousa, Lilían Andrade Carlos de Mendonça et al. 12 citations

Repeated ayahuasca administration before and during social isolation prevented depressive-like behaviors and cortisol alterations in common marmosets. Animals given ayahuasca showed higher cortisol reactivity and fecal cortisol levels similar to family-group controls, no signs of anhedonia, and no increase in chronic stress-related behaviors, unlike isolated animals that received no intervention. The findings suggest ayahuasca promotes resilient responses and may have a prophylactic action against depression.

Acute antidepressant effect of ayahuasca in juvenile non-human primate model of depression

bioRxiv (Cold Spring Harbor Laboratory) January 25, 2018 Flávia Santos Da Silva, Erick Allan Dos Santos Silva, Geovan Menezes de Sousa et al. 4 citations preprint

In a juvenile model of depression using common marmosets, a single dose of ayahuasca reversed depressive-like symptoms within 24 hours, including recovery of cortisol levels, reduced stereotypic scratching in males, increased feeding, and restored body weight in both sexes. The effects lasted 14 days. The study suggests ayahuasca produces faster and more durable antidepressant effects than the tricyclic antidepressant nortriptyline, supporting its potential as a treatment for early-age depression.

Trait mindfulness influences self-reported mental health in individuals with depression

Current Psychology June 1, 2026 Geovan Menezes de Sousa, Geissy Lainny de Lima-Araújo, Vagner Deuel de Oliveira Tavares et al.

Adults with major depressive disorder who report higher levels of dispositional mindfulness—the tendency to attend to present-moment experiences with openness and awareness—show fewer depressive and anxiety symptoms, better sleep quality, and higher self-esteem compared to those with lower trait mindfulness. In a cross-sectional study of 97 adults diagnosed with MDD, two clusters emerged: a High Trait group and a Low Trait group. The High Trait group had significantly lower depressive symptoms (d = 0.795) and anxiety symptoms (d = 0.739), and higher self-esteem (d = -0.586) and sleep quality (d = 0.460). These results suggest trait mindfulness may protect against poor mental health in depression.

Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy

medRxiv Preprint Server May 31, 2026 Yves Martins Varela, Patrícia Cavalcanti-Ribeiro, Geovan Menezes de Sousa et al. preprint

Ketamine rapidly reduces depression symptoms in treatment-resistant depression, but its effects may be enhanced by combining it with psychotherapy. The drug induces neuroplasticity and psychological openness, which could help patients process emotions, restructure thoughts, and maintain improvements. However, research has not yet thoroughly examined whether adding structured psychotherapy to ketamine treatment provides additional benefits.